Navigation Links
Syngenta and Devgen enter insect control research partnership
Date:5/13/2012

BASEL, Switzerland, May 14, 2012

  • License to access novel insect control technology
  • New range of biological solutions for hard-to-control insects
  • Development of new commercial offers for growers

Syngenta and Devgen today announced a six-year global license and research agreement. The partnership will enable Syngenta to add RNA interference (RNAi) technology to its crop protection pipeline. As of April 2013, the two companies will jointly develop new biological insect control solutions based on RNAi technology.

Under the agreement, Syngenta will develop and commercialize sprayable RNAi-based crop protection products originating from Devgen. Devgen will bolster its research activities through funding and royalties from Syngenta, consisting of an upfront technology access payment of EUR 22m and EUR 4.8m per year to fund research over the course of the agreement. Devgen is eligible to receive royalties from Syngenta on sales of developed products.

"We are pleased to enter this research partnership with Devgen given their leading position in RNAi research and proven expertise in RNAi-based insect control," said Sandro Aruffo, Global Head of Research and Development. "This novel technology further expands our growing range of biological insect control solutions."

"We are pleased to have Syngenta, a leading crop protection and seed company, as partner in the RNAi field. This relationship will enable Devgen to further and fully exploit the potential of this exciting technology for spray applications," says Thierry Bogaert, CEO of Devgen.

RNAi is a naturally occurring process in all organisms. In agriculture, RNAi is developed to target and control a specific pest, thereby protecting high-value crops with no harm to beneficial insects.

Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com

Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by terminology such as 'expect', 'would', 'will', 'potential', 'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. We refer you to Syngenta's publicly available filings with the U.S. Securities and Exchange Commission for information about these and other risks and uncertainties. Syngenta assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors. This document does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor.  

 

Syngenta International AG

Media Office

CH-4002 Basel

Switzerland

Tel: +41 61 323 23 23

Fax: +41 61 323 24 24

www.syngenta.com

Media contact:

Daniel Braxton

Switzerland +41 61 323 2323

Analyst/Investor contact:

Jennifer Gough

Switzerland +41 61 323 5059

USA +1 202 737 6521

 


'/>"/>
SOURCE Syngenta
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. USDA Approves Syngenta and John Deere for Broadened Biotechnology Endorsement for Corn Crop Insurance
2. Syngenta and Metabolon Inc. in Collaborative Research Agreement for Biochemical Profiling Technology
3. Syngenta Enters Into Research Collaboration With Anhui Academy, China
4. Syngenta Board Proposes Stefan Borgas to Become New Director
5. Syngenta holds Annual General Meeting
6. Syngenta Acquires Innovative Bio-Control Technology to Improve Usable Crop Yields
7. Syngenta Issues EUR 500 Million Eurobond
8. Syngenta and Evogene to Collaborate on Soybean Nematode Resistance
9. Syngenta Licenses Chromatin Gene Stacking Technology for Sugar Cane
10. Syngenta Ventures Invests in U.S. Biotech Company Metabolon
11. Syngenta joins Sustainability Consortium as Founding Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... (PRWEB) , ... February 21, 2017 , ... ... and biotech research and development (R&D), today announced the establishment of Genedata Limited ... Managing Director Kevin Teburi, a recognized expert in life science informatics. Creating the ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... facility at its headquarters laboratory in Poway, California. Based upon 12 years ... both in-house personnel and consultants, VetStem constructed and validated a state-of-the-art GMP stem ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017   ... US, an international IT solutions and managed services provider ... offering – Service Desk for Epic. The new service ... their internal Epic resources by giving physicians, nurses and ... IT specialists for tier-one support. This will allow hospital ...
(Date:2/20/2017)... ... February 20, 2017 , ... Global relationship ... been approved for full, active membership in the Canadian Direct Sellers Association (DSA) ... Chief Executive Officer Jeff Olson in 2011. Today Nerium International, with ...
Breaking Biology Technology:
(Date:2/14/2017)... N.C. , Feb. 14, 2017  Wake Forest ... M.D., as its new chief executive officer (CEO). Freischlag ... CEO John D. McConnell , M.D., who last ... position at the Medical Center, after leading it since ... the full scope of Wake Forest Baptist,s academic health ...
(Date:2/10/2017)... , Feb 10, 2017 Research ... report "Personalized Medicine - Scientific and Commercial Aspects" ... ... medicine. Diagnosis is integrated with therapy for selection of treatment ... early detection and prevention of disease in modern medicine. Biochip/microarray ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
Breaking Biology News(10 mins):